Drug intelligence / Profile preview

N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide is a synthetic small molecule with the molecular formula C23H35N5O2 and a molecular weight of 413.6 g/mol[1][3][6]. It is classified as an organic acid derivative, specifically an amide derivative of alpha amino acids[1][3]. The compound has been referenced in chemical and pharmacological databases but lacks detailed published information on its mechanism of action, clinical use, or therapeutic indication. No evidence was found for approval or advanced clinical development; it appears to be primarily characterized in chemical and experimental contexts.

Other names
(2S)-N-[(4-carbamimidoylphenyl)methyl]-1-[2-(cyclooctylamino)acetyl]pyrrolidine-2-carboxamide(2S)-N-((4-carbamimidoylphenyl)methyl)-1-(2-(cyclooctylamino)acetyl)pyrrolidine-2-carboxamide(2S)-N-[(4-carbamimidoylphenyl)methyl]-1-[2-(cyclooctylamino)ethanoyl]pyrrolidine-2-carboxamide

Beyond the preview

Go deeper on N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call